The Creat Group is a diversified equity investment company, headquartered in Beijing, and having branches and offices in China mainland, Hongkong, UK, US, Japan, Australia, etc.
The Group has businesses in both domestic and international markets through direct investing and fund investing, including the areas of manufacturing, pharmaceuticals, mineral resources, etc.
The Creat Group has 6 listed companies in following areas, including agriculture, food-processing, electrical equipment, overseas mining and pharmaceuticals. Shanghai RAAS Blood Products Co., Ltd, one of the listed companies, has valued at 6.5 billion dollars on the Shanghai Stock Exchange. The core valuation of Creat Group is: Credibility, Win-Win Cooperation, Innovation and tenacity.